This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a chiral center and difluorophenyl group, makes it valuable in the development of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. The difluorophenyl moiety enhances the compound's ability to interact with specific biological receptors, improving drug efficacy. Additionally, its hydrochloride form ensures better solubility and stability, facilitating its use in formulation processes. It is also employed in research and development for creating novel therapeutic agents, particularly in the field of enantioselective synthesis, where the chirality of the molecule plays a critical role in biological activity.